Waiting - relaxed - Dan quotes from interview7 Mar 2020 08:23
Quotes from interview on 20th February. Now, should a person believe Dan, who built this company from the start and actually knows what is happening or a BB poster? I'm going with the former.
****************************/articles/nuformix-open-orphan-and-chris-bailey-on-lloyds-hays-and-smith-nephew-50c227b
NXP001 – impacted by coronavirus but ‘We still expect these funds to come in’
NXP002 – ‘Really pleased with where things are. We want to get the best deal because I believe the outcome will be transformational for the business’
NXP002: 'I am still really happy with the way that negotiation is going and I am still hopeful that it will close in Q1.'
‘We are very comfortable right now with the small raise we did before Christmas, and ongoing income we have with Ebers activities allows us to progress both NXP002 and NXP004 programmes without delay or reliance on third parties.’
‘We’ve got a fantastic team, we’ve got some wonderful assets…the whole team feels that there is tremendous value in the business and we are all highly incentivised to take things forward.’
‘Our technology is proven, we’ve been able to reduce that to practice in clinic, which validates the rest of the growing portfolio.’
‘We’re about to enter a really exciting phase, which is going to be transformational for the company, completing transactions and moving assets forward.
‘To be able to bring him (Karl Keegan) onto the team at this time is absolutely perfect for us. He’s got an excellent track record in delivering value across a range of capital markets life science companies and we’re really looking forward to rolling our sleeves up with him as we go forward over the next couple of months’.